- Home
- CRGX vs UTL Comparison
CRGX vs UTL Comparison
Compare CRGX & UTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRGX
- UTL
- Stock Information
- Founded
- CRGX 2021
- UTL 1984
- Country
- CRGX United States
- UTL United States
- Employees
- CRGX N/A
- UTL N/A
- Industry
- CRGX
- UTL Power Generation
- Sector
- CRGX
- UTL Utilities
- Exchange
- CRGX Nasdaq
- UTL Nasdaq
- Market Cap
- CRGX 964.5M
- UTL 957.6M
- IPO Year
- CRGX 2023
- UTL N/A
- Fundamental
- Price
- CRGX $16.00
- UTL $59.07
- Analyst Decision
- CRGX Strong Buy
- UTL
- Analyst Count
- CRGX 7
- UTL 0
- Target Price
- CRGX $30.33
- UTL N/A
- AVG Volume (30 Days)
- CRGX 167.8K
- UTL 62.2K
- Earning Date
- CRGX 11-12-2024
- UTL 11-04-2024
- Dividend Yield
- CRGX N/A
- UTL 2.87%
- EPS Growth
- CRGX N/A
- UTL 5.48
- EPS
- CRGX N/A
- UTL 2.92
- Revenue
- CRGX N/A
- UTL $496,900,000.00
- Revenue This Year
- CRGX N/A
- UTL $0.88
- Revenue Next Year
- CRGX N/A
- UTL $4.75
- P/E Ratio
- CRGX N/A
- UTL $20.29
- Revenue Growth
- CRGX N/A
- UTL N/A
- 52 Week Low
- CRGX $13.56
- UTL $45.26
- 52 Week High
- CRGX $33.92
- UTL $63.52
- Technical
- Relative Strength Index (RSI)
- CRGX 32.69
- UTL 53.41
- Support Level
- CRGX $19.96
- UTL $57.55
- Resistance Level
- CRGX $23.00
- UTL $61.22
- Average True Range (ATR)
- CRGX 1.79
- UTL 1.71
- MACD
- CRGX -0.58
- UTL 0.18
- Stochastic Oscillator
- CRGX 7.04
- UTL 75.85
About CRGX CARGO Therapeutics Inc.
Cargo Therapeutics Inc is a clinical-stage biotechnology company positioned to advance next generation, potentially curative cell therapies for cancer patients. It programs, platform technologies, and manufacturing plan are designed to directly address the key limitations of approved cell therapies, including limited durability of effect, suboptimal safety and unreliable supply. The company's program, CRG-022, is a novel CAR T-cell product candidate designed to address resistance mechanisms by targeting CD22, an alternate tumor antigen that is expressed in a vast majority of B-cell malignancies.
About UTL UNITIL Corporation
Unitil Corp is a holding company, through its subsidiaries it is engaged in the local distribution of electricity and natural gas throughout its service territories in the states of New Hampshire, Massachusetts, and Maine. It reports three segments namely utility gas operations, utility electric operations, and non-regulated.